Literature DB >> 1961983

Genetics of antigenic variation in African trypanosomes.

E Pays1.   

Abstract

The major surface antigens of Trypanosoma brucei are the VSG (variant surface glycoprotein) at the bloodstream stage, and procyclin at the procyclic stage. Variation in the VSG allows the parasite to escape the antibody response of its mammalian host. This occurs through either DNA rearrangement in the telomeric VSG gene expression site, or alternate activation, without DNA rearrangement, of different telomeric expression sites. The VSG and procyclin genes each belong to large, polycistronic transcription units. Although the promoters of these units are both active at the two main stages of the parasite life cycle, stage-specific controls operating at the level of RNA elongation and processing lead to strictly differential expression of the end products of the two units. Despite their mutually exclusive control of expression, the VSG and procyclin transcription units share common characteristics. Both contain a similar gene, and both are transcribed by the same type of RNA polymerase, unusually resistant to alpha-amanitin. Among the eight genes present in the VSG transcription unit, two may be involved in the synthesis of cyclic AMP. The function of the other genes is unknown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1961983     DOI: 10.1016/0923-2508(91)90088-r

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  7 in total

1.  A proposed mechanism for promoter-associated DNA rearrangement events at a variant surface glycoprotein gene expression site.

Authors:  K M Gottesdiener; L Goriparthi; J P Masucci; L H Van der Ploeg
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  Trypanosome variant surface glycoproteins are recognized by self-reactive antibodies in uninfected hosts.

Authors:  N Müller; J M Mansfield; T Seebeck
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  PARP promoter-mediated activation of a VSG expression site promoter in insect form Trypanosoma brucei.

Authors:  T P Urményi; L H Van der Ploeg
Journal:  Nucleic Acids Res       Date:  1995-03-25       Impact factor: 16.971

4.  A monocistronic transcript for a trypanosome variant surface glycoprotein.

Authors:  C M Alarcon; H J Son; T Hall; J E Donelson
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

5.  Interleukin-4-dependent immunoglobulin G1 isotype switch in the presence of a polarized antigen-specific Th1-cell response to the trypanosome variant surface glycoprotein.

Authors:  L R Schopf; H Filutowicz; X J Bi; J M Mansfield
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach.

Authors:  Luke Mercer; Tana Bowling; Joe Perales; Jennifer Freeman; Tien Nguyen; Cyrus Bacchi; Nigel Yarlett; Robert Don; Robert Jacobs; Bakela Nare
Journal:  PLoS Negl Trop Dis       Date:  2011-02-08

7.  Sequencing of the smallest Apicomplexan genome from the human pathogen Babesia microti.

Authors:  Emmanuel Cornillot; Kamel Hadj-Kaddour; Amina Dassouli; Benjamin Noel; Vincent Ranwez; Benoît Vacherie; Yoann Augagneur; Virginie Brès; Aurelie Duclos; Sylvie Randazzo; Bernard Carcy; Françoise Debierre-Grockiego; Stéphane Delbecq; Karina Moubri-Ménage; Hosam Shams-Eldin; Sahar Usmani-Brown; Frédéric Bringaud; Patrick Wincker; Christian P Vivarès; Ralph T Schwarz; Theo P Schetters; Peter J Krause; André Gorenflot; Vincent Berry; Valérie Barbe; Choukri Ben Mamoun
Journal:  Nucleic Acids Res       Date:  2012-07-24       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.